Innovation and Collaboration
MRC Integrative Epidemiology Unit
We have an active collaboration with Professor George Davey Smith, head of the MRC Integrative Epidemiology unit at the University of Bristol. With more than 1000 peer-reviewed academic publications, he has been highly successful in multiple fields of epidemiology, from life-course epidemiology and the population health contributions of the new genetics to systematic reviewing of evidence of effectiveness of health care and health policy interventions. He has been highly successful in developing novel causal analysis methods in population-based and clinical health sciences. Of particular relevance to our collaboration, he has pioneered the development of Mendelian Randomization analyses, a novel technique that utilizes genetic variation to examine causal associations in observational studies.
MR Cancer Group
The MR Cancer Group focuses on the use of imaging and molecular analyses to describe functional and metabolic characteristics of cancer. The group has more than 25 years of experience from clinical MRI and NMR based metabolomics studies in cancer, and aim to improve the understanding of underlying biological processes by applying multilevel molecular analysis methods to biological data. The Jebsen Center works closely with Associate Professor May-Britt Tessem.
Sepsis Research Center
The Sepsis Center´s research takes place in the multidisciplinary fields of epidemiology, genetics, microbiology, molecular biology, intensive care, statistics, economics, bioinformatics and innovation. They work closely with clinicians and use data from one of the world's largest sepsis registries to find solutions for diagnosis, treatment and follow-up of sepsis patients.
Institute of Clinical Medicine
John-Anker Zwart is head of research at the Division for Surgery and Clinical Neuroscience, Oslo University Hospital (OUS) and UiO. Zwart is also the director of The Musculoskeletal Research Unit at OUS and chair for the Clinical International Headache Genetics consortium and the International Low-Back-Pain consortium.
The Tromsø Study
The Tromsø Study has provided considerable information on what influences the risk of contracting common, but serious, diseases. Inger Njølstad is a Professor in Epidemiology with a special interest in CVD and diabetes. She has been the PI for the Tromsø study since 2005
Other important collaborations
- Genetics of Osteoarthritis consortium (GO)
- Nightingale Health - Large scale metabolomics
- Olink - Proteomics
- Karolinska Institutet - Psoriasis
- The Kavli Institute - Alzheimer´s disease
- Statens Serum Institut - Danmarks Nationale Biobank
- University of Dundee - Eczema
- QIMR Berghofer - Asthma
- University of Queensland - Birth weight
- Harvard Medical School - Insomnia
- Leicester City CCG - Lung function
- Cardiff University - Thyroid function
- Lund University - Subclassification of T2D
- Broad Institute of MIT and Harvard - Atrial Fibrillation
- Technical University of Denmark - Ischemic heart disease
- KGJ TREC - VTE
- KGJN - OCD
- KGJ Diabetes - Diabetes
- KGJ PsychDis - Dementia
- CERG - Hypertension
- Twin Gene - PCSK9, lipids
- UK Biobank - GWAS
- deCode - GWAS
- Framingham Heart Study - CVD
- Regeneron - Asthma
- Bayer Pharmaceutical - Anticoagulant
- FinHIT - Microbiota and GWAS
- University of Helsinki - CRC